Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
New Post
DOJ Issues New FCPA Enforcement Guidelines Focused on U.S. Economic and National Security Interests
June 12, 2025
Insight
World Bank debars Philippines-based construction company for four and a half years
May 29, 2025
News Alert